Full-Time

Field Service Engineer

Probes Team

Posted on 7/30/2026

Deadline 7/30/27
Bruker Corporation

Bruker Corporation

1,001-5,000 employees

Develops analytical instruments for scientific research

Compensation Overview

$71k - $113.5k/yr

+ Performance-related incentive + 401(k) match + Employee stock purchase plan

No H1B Sponsorship

Billerica, MA, USA

In Person

Domestic and international travel is required.

US Citizenship, US Top Secret Clearance Required

Category
Hardware Engineering (1)
Required Skills
CAD
Microsoft Office
Computer Networking

Get referred to Bruker Corporation

See people who can refer or advise you

Requirements
  • A Bachelor of Science degree in Chemistry, Biology, Engineering, or a Biotechnology discipline is required.
  • At least 3 years of hands-on experience operating and troubleshooting nuclear magnetic resonance equipment is required.
  • Ability to run samples and read spectra reports.
  • Strong technical skills involving analytical instrumentation.
  • Ability to communicate and interact with scientists with Ph.D. or Master’s degrees in Biochemistry, Biophysics, or Microbiology.
  • Ability to read and understand technical drawings and related materials to troubleshoot and diagnose issues to the component level.
  • Fluency in spoken and written English, with verbal, written, Microsoft Office, computer, technical data, networking, communication, and presentation skills.
  • Ability to work independently, prioritize, multitask, follow through, and meet deadlines.
  • Ability to complete position compliance and training requirements.
  • Ability to participate in quarterly scientific technical training programs.
  • Ability to lift up to 75 pounds and transport equipment and tools exceeding 300 pounds.
  • Reasonable dexterity to perform manual functions in confined spaces.
  • Ability to follow safety standards, practices, and codes.
  • Reliable transportation and a valid driver's license in good standing issued by the employee's resident state are required.
  • U.S. citizenship or U.S. permanent resident status is required.
  • A valid passport and flexibility for domestic and international travel are required.
  • May be required to pass a security clearance investigation.
Responsibilities
  • Test and validate repaired and returned equipment.
  • Run samples, analyze results, and report findings.
  • Perform requalification of used systems and preventive and corrective maintenance.
  • Provide technical assistance to test, install, service, and repair probes and equipment.
  • Communicate and work closely with the Service and Support Center, Regional Service Management, and Applications Specialists.
  • Install new or modified systems or accessories at customer facilities and ensure full functionality according to specifications.
  • Familiarize and train customers in basic operation of the equipment.
  • Secure customer acceptance of installation and repair sign-off.
  • Requalify the entire instrument after service repair by running complex compounds for verification.
  • Serve as a communication link between the customer and company to support customer service satisfaction.

Bruker Corporation provides analytical and diagnostic instruments used in life sciences, materials science, and environmental analysis. Its product lines include technologies such as nuclear magnetic resonance (NMR), mass spectrometry, imaging, and spectroscopy, which help researchers analyze the composition, structure, and properties of samples. These instruments work by measuring physical signals (like magnetic resonance, ion fragmentation patterns, or spectral fingerprints) from samples and translating them into data and insights via specialized software and workflows. Bruker differentiates itself through a long history of NMR expertise since 1960, a broad, integrated portfolio of measurement platforms, and a global footprint that supports researchers from development to routine analysis. Its goal is to empower scientists and industry professionals to advance research and solve real-world problems by providing reliable analytical tools and solutions.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Billerica, Massachusetts

Founded

1960

Get referred to Bruker Corporation

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • DISQVER targets sepsis, endocarditis, and bloodstream infections with under-24-hour analysis.[1]
  • Bruker can cross-sell NGS, AST, hygiene, and molecular diagnostics into hospitals.[1]
  • Select acquisition of distressed IP and staff can expand capabilities efficiently.[1]

What critics are saying

  • DISQVER remains research use only, delaying diagnostic revenue until registration completes.[1]
  • Noscendo's insolvency exposed weak commercialization and hospital budget pressure.[1]
  • Bruker faces integration risk from acquired software, IP, and select personnel.[1]

What makes Bruker Corporation unique

  • Founded by Günther Laukien in 1960, rooted in NMR innovation.[1][5]
  • Broad portfolio spans analytical instruments, diagnostics, microscopy, and semiconductor metrology.[1]
  • DISQVER adds metagenomic blood testing to Bruker's infection-diagnostics platform.[1]

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Sick Leave

Paid Holidays

Disability Insurance

Life Insurance

Dental Insurance

Flexible Work Hours

Employee Discounts

Growth & Insights and Company News

Headcount

6 month growth

14%

1 year growth

14%

2 year growth

14%
brutkasten GmbH
Jul 23rd, 2026
Bruker acquires DISQVER platform from insolvent German diagnostics startup Noscendo

US life sciences company Bruker has acquired the DISQVER platform and selected assets of insolvent German diagnostics startup Noscendo through a restructuring sale. Financial terms were not disclosed. Duisburg-based Noscendo, founded in 2016, developed a method for identifying pathogens in under 24 hours using next-generation sequencing from cell-free DNA. The technology is used by university hospitals for sepsis diagnostics. Despite raising nearly €40 million in venture capital, commercialisation proceeded slower than expected due to delays in selective contracts and economic pressure on hospitals. A planned financing round with existing investors failed in February 2026, leading to insolvency proceedings in March. Insolvency administrator Sarah Wolf from Anchor Rechtsanwälte said the restructuring preserved the technology's value for creditors and partners. Bruker acquired the patent-protected software, intellectual property rights, and select IT and sales staff in Duisburg. The laboratory in Kusterdingen was partially closed in April.